INmune Bio (NasdaqCM:INMB) Update / briefing Transcript

INmune Bio (NasdaqCM:INMB) Update / briefing February 26, 2026 01:00 PM ET Company ParticipantsAnna Martinez - Principal Investigator of the MissionEB Clinical TrialDavid Moss - Co-founder and CEOMark Lowdell - Chief Scientific Officer and Co-FounderDavid MossHi, everyone. Thanks for joining. I just want to let you know that we'll get started in about 1 minute or so. Good afternoon, everyone, thank you for joining us. I'm David Moss, CEO of INmune Bio. Today, we're proud to share pivotal updates regarding o ...